Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women

被引:63
|
作者
Gambacciani, M [1 ]
Ciaponi, M [1 ]
Cappagli, B [1 ]
Monteleone, P [1 ]
Benussi, C [1 ]
Bevilacqua, G [1 ]
Genazzani, AR [1 ]
机构
[1] Univ Pisa, Dept Obstet & Gynecol, I-56100 Pisa, Italy
关键词
estradiol; noretisterone acetate; hormonal replacement therapy; quality of life;
D O I
10.1016/S0378-5122(02)00327-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To describe the effects of low dose hormonal replacement therapy (LD-HRT) on quality of life in early postmenopausal women, since the postmenopausal estrogen deprivation in mid age women often brings along a series of changes and symptoms, which may greatly affect quality of life. Methods: Fifty normal postmenopausal women were recruited and randomly treated with LD-HRT, 17beta-estradiol (1 mg/day) and norethisterone acetate (0.5 mg/day) (LD-HRT) or calcium supplement (controls). No significant differences in age, age at menopause, the presence of chronic diseases and socio-economic status were present in the two groups. The Women's Health Questionnaire (WHQ), a validated quality-of-life instrument for perimenopausal and postmenopausal women, was administered at baseline and after 6 and 12 weeks of treatment in both groups. Results: At baseline no significant differences in WHQ scores were present in the two groups. In the control group the scores in all different areas showed no significant modification either after 6 and 12 weeks of observation. Conversely, the LD-HRT group showed a significant decrease in the scores of vasomotor symptoms, somatic symptoms, anxiety/fear, depressed mood and sleep problem items. No effects on memory/concentration and menstrual symptoms areas were evident. Conclusion: Although quality of life is also and may be mainly influenced by socio-economic and cultural factors, LD-HRT definitively can improve not only vasomotor symptoms, but also more general aspects of physical and psychological well-being of symptomatic postmenopausal women. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [1] Effect of low-dose hormonal replacement therapy (combined estradiol 1mg and noretisterone acetate 0.5mg) on cardiovascular risk in early postmenopausal women
    Mirada, A
    López, X
    Barnes, E
    López, JS
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 584 - 584
  • [2] Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women
    Gambacciani, M
    Ciaponi, M
    Cappagli, B
    Genazzani, AR
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (05) : 1180 - 1185
  • [3] Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women
    Sturdee, D. W.
    Archer, D. F.
    Rakov, V.
    Lang, E.
    [J]. CLIMACTERIC, 2008, 11 (01) : 63 - 73
  • [4] Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women
    Gambacciani, M
    Ciaponi, M
    Cappagli, B
    Monteleone, P
    Benussi, C
    Bevilacqua, G
    Vacca, F
    Genazzani, AR
    [J]. MATURITAS, 2005, 50 (02) : 91 - 97
  • [5] Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: A double-blind, randomised study
    Polisseni, Alvaro Fernando
    Leite Andrade, Amaury Teixeira
    Ribeiro, Luiz Claudio
    Castro, Isabela Queiros
    Brandao, Marcos
    Polisseni, Fernanda
    Guerra, Martha de Oliveira
    [J]. MATURITAS, 2013, 74 (02) : 172 - 178
  • [6] Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations
    Symons, J
    Kempfert, N
    Speroff, L
    [J]. OBSTETRICS AND GYNECOLOGY, 2000, 96 (03): : 366 - 372
  • [7] One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women
    Samsioe, Goran
    Dvorak, Vladimir
    Genazzani, Andrea R.
    Hamann, Bernd
    Heikkinen, Jorma
    Mueck, Alfred O.
    Suzin, Jacek
    Kawakami, Fernando T.
    Ferreira, Alberto
    Sun, Dongming
    Arguinzoniz, Miguel
    [J]. MATURITAS, 2007, 57 (02) : 171 - 181
  • [8] Efficacy and safety of a new, low-dose estradiol acetate formulation for menopausal symptoms
    Ellman, H
    Gilbert, RD
    Haney, AF
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 63S - 63S
  • [9] Effects of low-dose 17-β-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women
    Kaleli, B
    Yildirim, B
    Demir, S
    Alatas, E
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (12) : 1107 - 1111
  • [10] Low-dose estradiol combined with dydrogesterone relieves climacteric symptoms and improves quality of life
    Quereux, C
    Mijatovic, V
    van der Mooren, J
    Kenemans, P
    Pigne, A
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 589 - 589